{"chunk_id": "medquad__chunk_34168", "source": "medquad", "text": "y is symptomatic and supportive.\",NINDS,Inclusion Body Myositis\nWhat is the outlook for Inclusion Body Myositis ?,IBM is generally resistant to all therapies and its rate of progression appears to be unaffected by currently available treatments.,NINDS,Inclusion Body Myositis\nwhat research (or clinical trials) is being done for Inclusion Body Myositis ?,\"The National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAM"}